1. Home
  2. BXC vs MRVI Comparison

BXC vs MRVI Comparison

Compare BXC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluelinx Holdings Inc.

BXC

Bluelinx Holdings Inc.

HOLD

Current Price

$59.93

Market Cap

443.9M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.71

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXC
MRVI
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
443.9M
449.6M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
BXC
MRVI
Price
$59.93
$3.71
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$88.67
$4.58
AVG Volume (30 Days)
103.7K
1.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$2,948,840,000.00
$192,435,000.00
Revenue This Year
$1.54
N/A
Revenue Next Year
$4.30
$9.04
P/E Ratio
$35.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$52.71
$1.67
52 Week High
$130.06
$6.21

Technical Indicators

Market Signals
Indicator
BXC
MRVI
Relative Strength Index (RSI) 46.43 58.96
Support Level $59.45 $3.32
Resistance Level $65.99 $3.76
Average True Range (ATR) 3.21 0.22
MACD 0.96 0.00
Stochastic Oscillator 56.93 81.00

Price Performance

Historical Comparison
BXC
MRVI

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: